AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZYME
  4. [SCHEDULE 13G/A] Zymeworks Inc. SEC Filing

[SCHEDULE 13G/A] Zymeworks Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock ZYME logo
Zymeworks

NASDAQ:ZYME

ZYME Rankings

#2575 Ranked by Market Cap
N/A Ranked by Dividends

ZYME Latest News

Aug 19, 2025
Zymeworks Announces Participation in Upcoming Investor Conferences
Aug 11, 2025
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
Aug 7, 2025
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Jul 28, 2025
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate
Jul 17, 2025
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

ZYME Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Zymeworks Inc. SEC Filing
Aug 12, 2025
[Form 4] Zymeworks Inc. Insider Trading Activity
Aug 12, 2025
[Form 4] Zymeworks Inc. Insider Trading Activity
Aug 12, 2025
[Form 3] Zymeworks Inc. Initial Statement of Beneficial Ownership
Aug 12, 2025
[Form 3] Zymeworks Inc. Initial Statement of Beneficial Ownership

ZYME Stock Data

1.09B
72.69M
0.15%
102.9%
9.18%
Biotechnology
Pharmaceutical Preparations
United States
MIDDLETOWN